Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Boc-Piperazine-2-F-Ph-CHO

Boc-Piperazine-2-F-Ph-CHO (Compound 2) is a PROTAC linker, used for the synthesis of YD54 (HY-168221) [1].

Product Specifications

CAS Number

[501126-37-0]

UNSPSC

12352005

Target

PROTAC Linkers

Type

Reference compound

Related Pathways

PROTAC

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/boc-piperazine-2-f-ph-cho.html

Purity

97.0

Smiles

FC1=C(C=CC(C=O)=C1)N2CCN(C(OC(C)(C)C)=O)CC2

Molecular Formula

C16H21FN2O3

Molecular Weight

308.35

References & Citations

[1]Kotagiri S, et al. Discovery of Novel, Potent and Orally Bioavailable SMARCA2 PROTACs with Synergistic Anti-tumor Activity in Combination with KRAS G12C Inhibitors. bioRxiv [Preprint]. 2024 Aug 26:2024.08.23.608456.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light, stored under nitrogen)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Mouse Monoclonal TGF-alpha Antibody (TG86) [HRP]
NBP2-34722H 0.1 mL

Mouse Monoclonal TGF-alpha Antibody (TG86) [HRP]

Sign In for Pricing
View Details
Imoxiterol 10mg
A19283-10 10 mg

Imoxiterol 10mg

Sign In for Pricing
View Details
NVP-BAG956 25mg
A11511-25 25 mg

NVP-BAG956 25mg

Sign In for Pricing
View Details
50nm Stabilized Gold Nanoparticles
CG-50-1000 1000 mL

50nm Stabilized Gold Nanoparticles

Sign In for Pricing
View Details
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/796), CF647 conjugate, 0.1mg/mL
BNC471879-500 1x 500 µL

Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/796), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Recombinant Human BLIMP1/PRDM1 Protein - (Dry Ice)
H00000639-Q01-10ug 10 µg

Recombinant Human BLIMP1/PRDM1 Protein - (Dry Ice)

Sign In for Pricing
View Details